TRAM2 is driven by an enhancer to induce epithelial-to-mesenchymal cell transition in breast cancer cells, which is involved in cell proliferation invasion and migration, and high TRAM2 expression is associated with poor survival in cancer patients [35,36]. This evidence concerns the gene TRAM2 and cancer.